BCI Marketplace
Brain-Computer Interface trials

UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

RecruitingNCT06992596Phase: NAStarted 2025-05-09

Summary

The UAE-PRIME Study is a feasibility study designed to assess the initial clinical safety and functionality of the Neuralink N1 Implant and R1 Robot. This study involves participants who have tetraparesis, tetraplegia, or a diagnosis that may lead to these conditions. The N1 Implant is a wireless, rechargeable device mounted on the skull, connected to electrode threads that are inserted into the brain by the R1 Robot, which is a robotic device specifically designed for this procedure.

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
None

Inclusion Criteria: * (a) A diagnosis of a spinal cord injury (\>12 months), stroke (\>12 months), or other neurological condition causing the participant to experience bilateral upper limb motor impairment, with no expectation of recovery. OR (b) A diagnosis of Amyotrophic Lateral Sclerosis (ALS)

Locations

Cleveland Clinic Abu Dhabi (CCAD)
Abu Dhabi, United Arab Emirates

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →